Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Objective: To study the incidence of de novo multimorbidity across all ages in a geographically defined population with an emphasis on sex and ethnic differences. Design: Historical cohort study. Setting: All persons residing in Olmsted County, Minnesota, USA on 1 January 2000 who had granted permission for their records to be used for research (n=123 716). Participants: We used the Rochester Epidemiology Project medical records-linkage system to identify all of the county residents. We identified and removed from the cohort all persons who had developed multimorbidity before 1 January 2000 (baseline date), and we followed the cohort over 14 years (1 January 2000 through 31 December 2013). Main outcome measures: Incident multimorbidity was defined as the development of the second of 2 conditions (dyads) from among the 20 chronic conditions selected by the US Department of Health and Human Services. We also studied the incidence of the third of 3 conditions (triads) from among the 20 chronic conditions. Results: The incidence of multimorbidity increased steeply with older age; however, the number of people with incident multimorbidity was substantially greater in people younger than 65 years compared to people age 65 years or older (28 378 vs 6214). The overall risk was similar in men and women; however, the combinations of conditions (dyads and triads) differed extensively by age and by sex. Compared to Whites, the incidence of multimorbidity was higher in Blacks and lower in Asians. Conclusions: The risk of developing de novo multimorbidity increases steeply with older age, varies by ethnicity and is similar in men and women overall. However, as expected, the combinations of conditions vary extensively by age and sex. These data represent an important first step toward identifying the causes and the consequences of multimorbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Chronological age is the major predictor for most of the diseases that account for the bulk of morbidity, mortality and health costs across low-, middle- and high-income countries2–7.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“The clearest evidence of age being the biggest risk factor for age-related diseases, and the accumulation of senescent cells is closely related to the occurrence of many chronic diseases [163, 164].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
Porta, M. (2026) · doi:10.1093/acref/9780197663639.001.0001 · Cited by 2,175
Epidemiology: Beyond the Basics
Szklo, M., & Nieto, F. J. (1999) · Cited by 1,441
Multimorbidity in Older Adults
Salive, M. E. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs009 · Cited by 1,341 · cited 3×
“Prior studies of the prevalence of multimorbidity have shown a dramatic increase in the number of people living with two or more chronic conditions at older ages.(1) 7–12 However, the high prevalence of multimorbidity in the older population implies that relatively few older individuals remain at risk of developing mu…”
BackgroundInfluentialVogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B., & Blumenthal, D. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0322-1 · Cited by 1,150
van den Akker, M., Buntinx, F., Metsemakers, J. F. M., Roos, S., & Knottnerus, J. A. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00306-5 · Cited by 1,027
Multimorbidity patterns: a systematic review
Prados-Torres, A., Calderón-Larrañaga, A., Hancco-Saavedra, J., Poblador-Plou, B., & van den Akker, M. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.09.021 · Cited by 808
Defining and Measuring Chronic Conditions: Imperatives for Research, Policy, Program, and Practice
Goodman, R. A., Posner, S. F., Huang, E. S., Parekh, A. K., & Koh, H. K. (2013) · Preventing Chronic Disease · doi:10.5888/pcd10.120239 · Cited by 807 · cited 3×
“24 The list of the 20 conditions and the corresponding International Classification of Diseases Ninth Edition (ICD-9) codes used in this study are provided in online supplementary table SA.(23) 24 We first identified all ICD-9 codes associated with these 20 chronic conditions that occurred in the population between 1…”
MethodInfluentialRocca, W. A., Yawn, B. P., St. Sauver, J. L., Grossardt, B. R., & Melton, L. J. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.012 · Cited by 791 · cited 1×
“In this study, we further leveraged this data resource to examine the incidence of multimorbidity across all ages, separately in men and women and in three ethnic groups.(17)”
MethodSelf-citationSmith, S. M., Soubhi, H., Fortin, M., Hudon, C., & O'Dowd, T. (2012) · BMJ · doi:10.1136/bmj.e5205 · Cited by 740 · cited 1×
“7–12 Additional studies have focused on how to manage patients with multiple chronic conditions.(13) 14 However, in 2010 the US Department of Health and Human Services (US-DHHS) highlighted the critical need to identify groups of individuals at higher risk of developing multimorbidity (first appearance of multimorbidi…”
Background
Cited by
Inflammation and aging: signaling pathways and intervention therapies
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443
From discoveries in ageing research to therapeutics for healthy ageing
Campisi, J., Kapahi, P., Lithgow, G. J., Melov, S., Newman, J. C., & Verdin, E. (2019) · Nature · doi:10.1038/s41586-019-1365-2 · Cited by 1,389
Senolytic drugs: from discovery to translation
Kirkland, J. L., & Tchkonia, T. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13141 · Cited by 1,227
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Cellular senescence: a translational perspective
Kirkland, J. L., & Tchkonia, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.013 · Cited by 1,013
“Chronic diseases, including dementias, atherosclerosis, diabetes, blindness, kidney dysfunction, and osteoarthritis among many others, become more prevalent with increasing age and tend to cluster together within older individuals (St Sauver et al., 2015).”
Background
Metadata
- Authors
- St Sauver, J. L., Boyd, C. M., Grossardt, B. R., Bobo, W. V., Finney Rutten, L. J., Roger, V. L., Ebbert, J. O., Therneau, T. M., Yawn, B. P., & Rocca, W. A.
- Affiliations
- Johns Hopkins University (US)
- Mayo Clinic (US)
- Corresponding author
- Rocca, Walter A
- ORCID
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2015-02
- Volume
- 5
- Issue
- 2
- Pages
- e006413
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC4322195
- OpenAlex
- W2048353385
- Cited by
- 257
- References
- 40
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 26 · 2023: 36 · 2022: 29 · 2021: 22 · 2020: 27 · 2019: 21 · 2018: 22 · 2017: 17 · 2016: 14 · 2015: 8
- FWCI
- 15.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic (R01AG034676)
- John A. Hartford Foundation
- Hartford Foundation for Public Giving
- Starr Foundation
- National Institutes of Health
- National Institute on Aging (R01AG034676, K23AG032910, NIA K23 AG032910)
- Topics
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- multimorbidity, chronic disease, incidence, sex differences, ethnic differences, age differences, Olmsted County, Minnesota, Rochester Epidemiology Project, racial disparities
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Black or African American, Child, Preschool, Chronic Disease, Ethnicity, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Minnesota, Retrospective Studies, Sex Factors, Comorbidity, Incidence, Black People, White People, Asian People, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. https://app.cochat.ai/papers/10.1136/bmjopen-2014-006413
- The paper
- St Sauver, J. L., Boyd, C. M., Grossardt, B. R., Bobo, W. V., Finney Rutten, L. J., Roger, V. L., Ebbert, J. O., Therneau, T. M., Yawn, B. P., & Rocca, W. A. (2015). Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ Open. https://doi.org/10.1136/bmjopen-2014-006413
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.